Current status and recognition of inhaled nitrous oxide for the treatment of acute respiratory distress syndrome
10.3760/cma.j.issn.2095-428X.2016.18.009
- VernacularTitle:急性呼吸窘迫综合征的吸入一氧化氮治疗现状和再认识
- Author:
Yueqiang FU
;
Feng XU
- Publication Type:Journal Article
- Keywords:
Inhaled nitrous oxide;
Acute respiratory distress syndrome;
Child
- From:
Chinese Journal of Applied Clinical Pediatrics
2016;31(18):1390-1393
- CountryChina
- Language:Chinese
-
Abstract:
Inhaled nitrous oxide (iNO) can alleviate pulmonary hypertension and enhance ventilation-perfusion matching to improve oxygenation in pediatric acute respiratory distress syndrome (PARDS).But duration of improvement was short.From the existing researches,iNO can't effectively improve outcome in PARDS.So iNO is not recommended for routine use in PARDS.However,iNO may be used in patients with documented pulmonary hypertension or severe right ventricular dysfunction.In addition,iNO can be a rescue intervention for severely PARDS to buy time and allow other therapies.
